LEADER 01188nam2-2200397---450- 001 990001552260203316 005 20050110142633.0 035 $a000155226 035 $aUSA01000155226 035 $a(ALEPH)000155226USA01 035 $a000155226 100 $a20040401d1970----km-y0itay0103----ba 101 0 $aita 102 $aIT 105 $a||||||||001yy 200 1 $a<<4.>> : <> selezione sessuale$fHavelock Ellis$g[trad. di Anna Maria Amari] 210 $aRoma$cNewton Compton Italiana$d1970 215 $a335 p.$d19 cm 225 2 $aPaperbacks saggi$v25 410 0$12001$aPaperbacks saggi$v25 454 1$12001 461 1$1001000155214$12001$aPsicologia del sesso 606 0 $aSesso$xPsicologia 676 $a155.3 700 1$aELLIS,$bHavelock$0167762 702 1$aAMARI,$bAnna Maria 801 0$aIT$bsalbc$gISBD 912 $a990001552260203316 951 $aII.3. 105/4(Varie Coll. 79/25)$b25007 L.M.$cVarie Coll. 959 $aBK 969 $aUMA 979 $aSIAV4$b10$c20040401$lUSA01$h1234 979 $aPATRY$b90$c20040406$lUSA01$h1748 979 $aCOPAT2$b90$c20050110$lUSA01$h1426 996 $aSelezione sessuale$9940813 997 $aUNISA LEADER 04124nam 22012013a 450 001 9910367754603321 005 20250203235435.0 010 $a9783039216154 010 $a3039216155 024 8 $a10.3390/books978-3-03921-615-4 035 $a(CKB)4100000010106171 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/54644 035 $a(ScCtBLL)2766e7b8-8858-4e87-add9-3aa631700b49 035 $a(OCoLC)1163845648 035 $a(EXLCZ)994100000010106171 100 $a20250203i20192019 uu 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNewborn Screening for Sickle Cell Disease and other Haemoglobinopathies$fElena Cela, Jacques Elion, Stephan Lobitz, Raffaella Colombatti 210 1$aBasel, Switzerland :$cMDPI,$d2019. 215 $a1 electronic resource (162 p.) 311 08$a9783039216147 311 08$a3039216147 330 $aNewborn Screening for Sickle Cell Disease and other Haemoglobinopathies is a Special Issue of the International Journal of Neonatal Screening. Sickle cell disease is one of the most common inherited blood disorders, with a huge impact on health care systems due to high morbidity and high mortality associated with the undiagnosed disease. Newborn screening helps to make the diagnosis early and to prevent fatal complications and diagnostic odysseys. This book gives an overview of diagnostic standards in newborn screening for sickle cell disease and examples of existing newborn screening programs. 610 $aglucose-6-phosphate dehydrogenase 610 $ahydroxyurea/hydroxycarbamide 610 $acord blood 610 $ascreening 610 $ahemoglobin pattern 610 $acapillary electrophoresis 610 $asickle cell disease 610 $a(recommended) screening panel 610 $avaso-occlusive crisis 610 $aGuthrie spots 610 $anewborn screening) 610 $afoetal haemoglobin 610 $aharmonisation 610 $areview 610 $abirth prevalence 610 $aG6PD deficiency 610 $aprevention 610 $aend-organ damage 610 $athalassemia 610 $aMALDI-TOF 610 $aIEF 610 $aacute chest syndrome 610 $aIndia 610 $asickle cell and thalassaemia screening programme 610 $a'Getting to Outcomes' 610 $anewborn screening 610 $ahemoglobinopathy 610 $aservice users 610 $apublic health engagement 610 $aautomated HPLC 610 $aKaduna State 610 $agene therapy for haemoglobinopathies 610 $a?-globin gene 610 $amethods 610 $aneonatal screening program 610 $amalaria 610 $aPlasmodium vivax 610 $asub-Saharan Africa 610 $apatient organisations 610 $ahealth policy 610 $apathophysiology 610 $aSickle Cell Disease 610 $amass spectrometry 610 $asickle cell disorder 610 $aneonatal screening 610 $anon-tribal 610 $aNigeria 610 $apoint-of-care 610 $aHPLC 610 $alaboratory methods 610 $aregistry 610 $apatient advocacy 610 $abone marrow transplant 610 $aanaemia 610 $ahemoglobinopathies 610 $atribal 610 $anewborn 610 $aburden of disease 610 $apatient representatives 610 $adiagnostics 610 $apolicy making 610 $ahaemolysis 610 $aCaribbean 610 $ahigh performance liquid chromatography (HPLC) 610 $asickle cell disease (SCD) 610 $aimplementation science 700 $aCela$b Elena$01788596 702 $aElion$b Jacques 702 $aLobitz$b Stephan 702 $aColombatti$b Raffaella 801 0$bScCtBLL 801 1$bScCtBLL 906 $aBOOK 912 $a9910367754603321 996 $aNewborn Screening for Sickle Cell Disease and other Haemoglobinopathies$94323636 997 $aUNINA